Scholarlink

Purpose <p>Primary ovarian insufficiency (POI) is an important cause of female infertility, stemming from follicle dysfunction or premature oocyte depletion. Pathogenic variants in genes such as <i>NOBOX</i>, <i>GDF9</i>, <i>BMP15</i>, and <i>FSHR</i> have been linked to POI. NOBOX, a transcription factor expressed in oocytes and granulosa cells, plays a pivotal role in folliculogenesis. Loss-of-function variants in <i>NOBOX</i> are reported in 1–2% of POI women. This study aims to describe the association of novel <i>NOBOX</i> variants with a distinct oocyte, zygote, and embryo maturation arrest (OZEMA) phenotype in infertile women.</p> Methods <p>Three unrelated women experiencing OZEMA and undergoing multiple in vitro fertilization (IVF)&#xa0;cycles present with a germline <i>NOBOX</i> variant. The detected variants were cross-referenced with a large genetic database to explore their association with IVF outcomes.</p> Results <p>A heterozygous NM_001080413.3 (<i>NOBOX</i>): c.1797_1798del, p.(Cys600Phefs*27) variant was detected in a woman with oocyte maturation arrest. Another heterozygous variant, NM_001080413.3 (<i>NOBOX</i>): c.1849C &gt; T, p.(His617Tyr), was detected in two women experiencing embryonic developmental arrest. Segregation analysis in one of the two latter families revealed the presence of the p.(His617Tyr) variant in an affected sister, while the two fertile sisters did not carry this variant. Furthermore, the p.(His617Tyr) variant was found in three women in a large database of whom two presented with an embryonic developmental arrest.</p> Conclusion <p>Two heterozygous <i>NOBOX</i> variants were identified in women with an OZEMA phenotype. Where pathogenic <i>NOBOX</i> variants are typically linked to POI, our clinical findings suggest that NOBOX plays a role in subsequent oocyte maturation and early embryo development.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Oocyte/zygote/embryo maturation arrest: a clinical study expanding the phenotype of NOBOX variants

  • 期刊论文

  • 发表日期：

    2025年1月27日

查看全文
  • Annelore Van Der Kelen,
  • Sophie Uyttebroeck,
  • Stefanie Van de Voorde,
  • Ludovica Picchetta,
  • Ingrid Segers,
  • Jelle Vlaeminck,
  • Bart Johan H. Dequeker,
  • Philippe Giron,
  • Antonio Capalbo,
  • Willem Verpoest,
  • Frederik J. Hes,
  • Pieter Verdyck,
  • Alexander Gheldof

摘要

Purpose

Primary ovarian insufficiency (POI) is an important cause of female infertility, stemming from follicle dysfunction or premature oocyte depletion. Pathogenic variants in genes such as NOBOX, GDF9, BMP15, and FSHR have been linked to POI. NOBOX, a transcription factor expressed in oocytes and granulosa cells, plays a pivotal role in folliculogenesis. Loss-of-function variants in NOBOX are reported in 1–2% of POI women. This study aims to describe the association of novel NOBOX variants with a distinct oocyte, zygote, and embryo maturation arrest (OZEMA) phenotype in infertile women.

Methods

Three unrelated women experiencing OZEMA and undergoing multiple in vitro fertilization (IVF) cycles present with a germline NOBOX variant. The detected variants were cross-referenced with a large genetic database to explore their association with IVF outcomes.

Results

A heterozygous NM_001080413.3 (NOBOX): c.1797_1798del, p.(Cys600Phefs*27) variant was detected in a woman with oocyte maturation arrest. Another heterozygous variant, NM_001080413.3 (NOBOX): c.1849C > T, p.(His617Tyr), was detected in two women experiencing embryonic developmental arrest. Segregation analysis in one of the two latter families revealed the presence of the p.(His617Tyr) variant in an affected sister, while the two fertile sisters did not carry this variant. Furthermore, the p.(His617Tyr) variant was found in three women in a large database of whom two presented with an embryonic developmental arrest.

Conclusion

Two heterozygous NOBOX variants were identified in women with an OZEMA phenotype. Where pathogenic NOBOX variants are typically linked to POI, our clinical findings suggest that NOBOX plays a role in subsequent oocyte maturation and early embryo development.